|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit显示文摘 | Juliana Barr Gilles L. Fraser Kathleen Puntillo E. Wesley Ely Céline Gélinas Joseph F. Dasta Judy E. Davidson John W. Devlin John P. Kress Aaron M. Joffe Douglas B. Coursin Daniel L. Herr Avery Tung Bryce R. H. Robinson Dorrie K. Fontaine Michael A. Ramsa | 2013 | Critical Care Medicine2013，，1： | 6 |
| 2 | 红曲对中度血脂升高美国人调节血脂作用的临床研究显示文摘[目的]评价在饮食控制的情况下红曲(RYRCholestin)对美国高血脂人群的降脂作用和安全性。[方法]开放标记,自身对照,多中心临床试验。187名美国高血脂人群入选(血清低密度脂蛋白胆固醇3.50—4.92mmol/L,总胆固醇5.18—7.25mmol/L;男116人,女71人),162入完成试验。在整个试验中受试者遵照美国国家胆固醇教育计划的饮食要求。试验的前4周仅控制饮食,第5周至第12周连续服用8周RYRCholestin(每日2.4g)。[结果]经前4周饮食控制,血清脂质各指标无显著变化。口服RYRCholestin8周后,血清总胆固醇、低密度脂蛋白胆固醇和三酰甘油分别降低16.6%,24.O%和25.2%,高密度脂蛋白胆固醇升高14.3%(P〈0.001)。显效率为79.0%,有效率为97.5%。停服14d(2周)后,血脂各指标回到试验前水平。试验中共发现可能与服用产品相关的、轻度的29项不良反应。[结论]RYRCholestin的耐受性良好,它可降低血清总胆固醇、低密度脂蛋白胆固醇和三酰甘油,升高血清高密度脂蛋白胆固醇。停服2用后受试者的血脂各项指标均恢复到试验前水平。 | 陆继红 Kermit Bonovich Harry Colfer Michael Davidson Carlos A.Dujovne David L.Fried Mitchell Greenspan Ronald P.Karlsberg Stephen P.King Craig F.LaForce Marc Litt J.Robert McGhee 曾润海 朱佳石 谈宁芝 | 2013 | 上海预防医学2013，25，9： | 5 |
| 3 | 重载列车系统的动力效应对铁路斜拉桥地震响应的影响显示文摘本文为了评估重载列车系统的动力效应对大跨度铁路桥梁地震响应的影响,研究了重载列车静止在铁路斜拉桥上时的动力特性以及地震响应,采用了基于多刚体力学的空间车辆模型与附加质量模型两种不同的方式对车辆进行建模。计算中考虑了桥梁的几何非线性,并采用了三类地震波进行数值模拟。在对比有无车辆情况下的桥梁响应时,考虑了重载货车满载以及空载的因素。结果表明,在地震发生时,满载的列车会使得主梁弯矩以及拉索的索力峰值分别增加80%与40%,但是主梁的加速度峰值则会显著下降。证明了重载列车存在一定阻尼效应,且该阻尼效应对于满载列车来说更为显著。在此基础上,提出了一种用于桥梁抗震验算的简化2自由度车辆模型,并证明了其可靠性。 | 朱志辉 龚威 王琨 刘宇 DAVIDSON Michael T 蒋丽忠 | 2020 | Journal of Central South University2020，27，7： | 5 |
| 4 | Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport显示文摘 | Robert S. Rosenson H. Bryan Brewer W. Sean Davidson Zahi A. Fayad Valentin Fuster James Goldstein Marc Hellerstein Xian-Cheng Jiang Michael C. Phillips Daniel J. Rader Alan T. Remaley George H. Rothblat Alan R. Tall Laurent Yvan-Charvet | 2012 | Circulation2012，，15： | 4 |
| 5 | Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A 2 Testing into Cardiovascular Disease Risk Assessment Guidelines显示文摘 | Michael H. Davidson Marshall A. Corson Mark J. Alberts Jeffrey L. Anderson Philip B. Gorelick Peter H. Jones Amir Lerman Joseph P. McConnell Howard S. Weintraub | 2008 | The American Journal of Cardiology2008，，12： | 3 |
| 6 | Gastroenterology service in a teaching hospital in rural New Zealand, 1991-2003显示文摘AIM: To retrospectively collect inpatient and outpatient data and to assess the use of endoscopic procedures during the years 1991, 1997 and 2003 to analyse for trends. METHODS: This retrospective survey was conducted in a University-associated Gastroenterology Unit offering secondary and tertiary health care services for a population of approximately 182 000 people in Southern New Zealand. Data collected included patient contacts (inand outpatients), gastroscopic and colonoscopic investigations. RESULTS: We observed a significant increase in the absolute numbers of patient contacts over the years (1991: 2308 vs 1997: 2022 vs 2003: 2783, P < 0.0001) with inflammatory bowel disease, other diseases of the colon, anus and rectum and iron studies related disorders decreasing significantly but liver disease and constipation increasing linearly over time. The use of endoscopy services remained relatively stable but colonoscopic investigations for a positive family history of colorectal cancer increased significantly while more gastroscopies were performed for unexplained anaemia. CONCLUSION: The whole spectrum of gastroenterology contacts was studied. A substantial proportion of colonoscopies and outpatient consultations were undertaken to screen for colorectal cancer. This proportion is likely to grow further. Our fi ndings have implications for the recruitment and training of the next generation of gastroenterologists. | Michael Schultz Andrew Davidson Sarah Donald Bogna Targonska Angus Turnbull Susan Weggery Vicki Livingstone John D Dockerty | 2009 | World Journal of Gastroenterology2009，15，5： | 3 |
| 7 | Fondaparinux预防老年急性内科患者发生静脉血栓形成的效果与安全性:随机安慰剂对照研究显示文摘目的:观察 Fondaparinux 对具有中高度静脉血栓发生危险的老年急性内科住院患者的抗凝效果与安全性。设计:双盲随机安慰剂对照研究。背景:8个国家的35个中心。参与者:849例≥60岁内科患者,住院原因分别为充血性心力衰竭、慢性肺病合并急性呼吸系统疾患、急性炎症性或感染性疾病,预期至少住院4天以上。干预:2.5 mg Fondaparinux 或安慰剂,每天1次皮下注射,持续6~14天。观察指标:主要指标为静脉血栓形成(治疗后15天内采用双侧静脉造影检查)及有症状的静脉血栓;次要指标为死亡与出血。患者随访时间为1个月。结果:Fondaparinux 治疗组425例患者和安慰剂组414例患者接受了安全性分析(10例未治疗)。644例患者(75.9%)可接受主要指标分析。静脉血栓检出率在 Fondaparinux 治疗组为5.6%(18/321),安慰剂组为10.5%(34/323),相对危险减少46.7%(95% CI 7.7%~69.3%)。安慰剂组5例患者发生有症状的静脉血栓,Fondaparinux治疗组无患者发生有症状的静脉血栓(P=0.029)。两组均有1例(0.2%)患者发生严重出血。随访结束时,安慰剂组、Fondaparinux 治疗组分别死亡25(6.0%)、14(3.3%)例患者。结论:Fondaparinux 可有效预防急性内科老年患者无症状性及有症状的静脉血栓。严重出血几率两组相似。 | Alexander T Cohen Bruce L Davidson Alexander S Gallus Michael R Lassen Martin H Prins Witold Tomkowski Alexander G G Turpie Jan F M Egberts Anthonie W A Lensing 石汉平(译) 王深明(校) | 2006 | 英国医学杂志中文版2006，9，5： | 3 |
| 8 | Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region显示文摘 | Jim Gilbert Julie Lekstrom-Himes Debra Donaldson Yih Lee Mingxiu Hu Jing Xu Tim Wyant Michael Davidson | 2011 | The American Journal of Cardiology2011，，6： | 2 |
| 9 | Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit显示文摘 | Juliana Barr Gilles L. Fraser Kathleen Puntillo E. Wesley Ely Céline Gélinas Joseph F. Dasta Judy E. Davidson John W. Devlin John P. Kress Aaron M. Joffe Douglas B. Coursin Daniel L. Herr Avery Tung Bryce R. H. Robinson Dorrie K. Fontaine Michael A. Ramsa | 2013 | Critical Care Medicine2013，，1： | 2 |
| 10 | Novel nonstatin strategies to lower low-density lipoprotein cholesterol显示文摘 | Michael H. Davidson | 2009 | Current Atherosclerosis Reports2009，，1： | 2 |
| 11 | One thousand minimally invasive mitral valve operations: early outcomes, late outcomes and echocardiographic follow-up显示文摘 | R. Scott McClure Leonidas V. Athanasopoulos Siobhan McGurk Michael J. Davidson Gregory S. Couper Lawrence H. Cohn | 2012 | The Journal of Thoracic and Cardiovascular Surgery2012，，： | 2 |
| 12 | Comparison of the efficacy and safety of rosuvastatin versus atorvastatin , simvastatin , and pravastatin across doses (STELLAR * * STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)显示文摘 | Peter H Jones Michael H Davidson Evan A Stein Harold E Bays James M McKenney Elinor Miller Valerie A Cain James W Blasetto | 2003 | The American Journal of Cardiology2003，，2： | 2 |
| 13 | Efficacy and safety of simvastati n 80 mg /day in hypercholesterolemic patients显示文摘 | Evan A Stein Michael H Davidson | 1998 | Am J Cardiol1998，82，： | 1 |
| 14 | How Much does Labour Turnover Cost? - A Case Study of Australian Four- and Five-Star Hotels 显示文摘 | Michael C G Davidson Nils Timo Ying Wang | 2010 | International Journal of Contemporary Hospitality Management2010，22，4： | 1 |
| 15 | Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome显示文摘 | Carole L. Marcus Lee J. Brooks Sally Davidson Ward Kari A. Draper David Gozal Ann C. Halbower Jacqueline Jones Christopher Lehmann Michael S. Schechter Stephen Sheldon Richard N. Shiffman Karen Spruyt | 2012 | PEDIATRICS2012，，3： | 1 |
| 16 | Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD显示文摘 | Michael J. Koren Michael H. Davidson Daniel J. Wilson Rana S. Fayyad Andrea Zuckerman David P. Reed | 2009 | American Journal of Kidney Diseases2009，，5： | 1 |
| 17 | Natamycin显示文摘 | Michael Davidson P Craig H Doan | 1993 | University of Idaho1993，，7： | 1 |
| 18 | A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses显示文摘 | David Cameron Michelle Casey Michael Press Deborah Lindquist Tadeusz Pienkowski C. Gilles Romieu Stephen Chan Agnieszka Jagiello-Gruszfeld Bella Kaufman John Crown Arlene Chan Mario Campone Patrice Viens Neville Davidson Vera Gorbounova Johannes Isaac Raa | 2008 | Breast Cancer Research and Treatment2008，，3： | 1 |
| 19 | Physical, mechanical , and antibacterial properties of chitosan/PEO blend films显示文摘 | Zivanovic Svetlana Li J J Davidson P Michael | 2007 | Biomacromolecules2007，8，5： | 1 |
| 20 | Elimination of mitochondrial elements and improved viability in hybrid cells显示文摘 | Michael L. Ziegler Richard L. Davidson | 1981 | Somatic Cell Genetics1981，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员